hydroxychloroquine has been researched along with Cardiomyopathy, Restrictive in 6 studies
Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.
Cardiomyopathy, Restrictive: A form of CARDIAC MUSCLE disease in which the ventricular walls are excessively rigid, impeding ventricular filling. It is marked by reduced diastolic volume of either or both ventricles but normal or nearly normal systolic function. It may be idiopathic or associated with other diseases (ENDOMYOCARDIAL FIBROSIS or AMYLOIDOSIS) causing interstitial fibrosis.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We report two cases of hydroxychloroquine-induced hyperpigmentation presenting in a 50-year-old Caucasian female (case 1) and a 78-year-old female (case 2), both receiving 400 mg per day." | 7.74 | Hydroxychloroquine-induced hyperpigmentation: the staining pattern. ( Ferringer, T; Lountzis, NI; Puri, PK; Tyler, W, 2008) |
| "We report two cases of hydroxychloroquine-induced hyperpigmentation presenting in a 50-year-old Caucasian female (case 1) and a 78-year-old female (case 2), both receiving 400 mg per day." | 3.74 | Hydroxychloroquine-induced hyperpigmentation: the staining pattern. ( Ferringer, T; Lountzis, NI; Puri, PK; Tyler, W, 2008) |
| "Hydroxychloroquine was discontinued, and follow-up echocardiogram 57 days after discontinuation showed normalization of her left ventricular ejection fraction." | 2.55 | Restrictive Cardiomyopathy Associated With Long-Term Use of Hydroxychloroquine for Systemic Lupus Erythematosus. ( Cox, ZL; Mendes, LA; Sabato, LA, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Lodge, FM | 1 |
| Moody, WE | 1 |
| Tosounidou, S | 1 |
| Chue, CD | 1 |
| Curtis, E | 1 |
| Neil, DAH | 1 |
| Bradlow, W | 1 |
| Layoun, ME | 1 |
| Desmarais, J | 1 |
| Heitner, SB | 1 |
| Masri, A | 1 |
| Sabato, LA | 1 |
| Mendes, LA | 1 |
| Cox, ZL | 1 |
| Puri, PK | 1 |
| Lountzis, NI | 1 |
| Tyler, W | 1 |
| Ferringer, T | 1 |
| Manohar, VA | 1 |
| Moder, KG | 1 |
| Edwards, WD | 1 |
| Klarich, K | 1 |
| Cotroneo, J | 1 |
| Sleik, KM | 1 |
| Rene Rodriguez, E | 1 |
| Klein, AL | 1 |
1 review available for hydroxychloroquine and Cardiomyopathy, Restrictive
| Article | Year |
|---|---|
Restrictive Cardiomyopathy Associated With Long-Term Use of Hydroxychloroquine for Systemic Lupus Erythematosus.
Topics: Aged; Antimalarials; Cardiomyopathy, Restrictive; Drug Administration Schedule; Female; Humans; Hydr | 2017 |
5 other studies available for hydroxychloroquine and Cardiomyopathy, Restrictive
| Article | Year |
|---|---|
Hydroxychloroquine-induced cardiomyopathy accelerated after gastric banding.
Topics: Antirheumatic Agents; Cardiomyopathy, Restrictive; Echocardiography; Female; Gastroplasty; Heart; Hu | 2021 |
Hot hearts on bone scintigraphy are not all amyloidosis: hydroxychloroquine-induced restrictive cardiomyopathy.
Topics: Amyloidosis; Cardiomyopathies; Cardiomyopathy, Restrictive; Humans; Hydroxychloroquine; Radionuclide | 2020 |
Hydroxychloroquine-induced hyperpigmentation: the staining pattern.
Topics: Aged; Antacids; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents | 2008 |
Restrictive cardiomyopathy secondary to hydroxychloroquine therapy.
Topics: Antirheumatic Agents; Cardiomyopathy, Restrictive; Echocardiography; Female; Heart; Humans; Hydroxyc | 2009 |
Hydroxychloroquine-induced restrictive cardiomyopathy.
Topics: Antirheumatic Agents; Cardiomyopathy, Restrictive; Female; Humans; Hydroxychloroquine; Middle Aged | 2007 |